ACA: financial statements from SEC

Income statement

Metric	Dec 31, 2025	Dec 31, 2024
Revenue	2.88bn	2.57bn
Cost of revenue	2.24bn	2.05bn
Gross profit	647m	515m
Selling, general and administrative	307m	320m
Operating expenses	305m	318m
Operating income	342m	198m
Pre-tax income	241m	130m
Income tax	33m	36m
Net income	208m	94m
Earnings per share	4.25	1.92
Earnings per share, diluted	4.24	1.91
Weighted average shares	49m	49m
Weighted average shares, diluted	49m	49m

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	153m	215m	220m	190m	168m	187m	757m	104m
Receivables	414m	418m	480m	477m	428m	350m	396m	443m
Inventory	350m	424m	421m	407m	365m	360m	360m	406m
Current assets	1.13bn	1.11bn	1.17bn	1.12bn	1.01bn	954m	1.56bn	991m
Property, plant and equipment	2.10bn	2.10bn	2.09bn	2.10bn	2.12bn	2.13bn	1.38bn	1.42bn
Goodwill	1.34bn	1.35bn	1.35bn	1.34bn	1.34bn	1.36bn	1.01bn	1.02bn
Total assets	5.00bn	4.99bn	5.05bn	5.01bn	4.93bn	4.92bn	4.36bn	3.81bn
Current liabilities	490m	504m	580m	528m	510m	516m	432m	429m
Long-term debt	1.51bn	1.51bn	1.57bn	1.67bn	1.68bn	1.68bn	1.23bn	700m
Total liabilities	2.35bn	2.34bn	2.47bn	2.50bn	2.48bn	2.49bn	1.92bn	1.39bn
Equity	2.65bn	2.64bn	2.58bn	2.51bn	2.45bn	2.43bn	2.43bn	2.42bn
Shares outstanding	—	49m	—	—	—	49m	—	—
Shares issued	—	49m	—	—	—	49m	—	—

Metric	Dec 31, 2025	Dec 31, 2024
Operating cash flow	341m	502m
Depreciation and amortisation	223m	195m
Share-based compensation	26m	24m
Capital expenditure	166m	190m
Investing cash flow	−121m	−1.51bn
Dividends paid	10m	10m
Share buybacks	0	0
Financing cash flow	−192m	1.09bn